13F Holdings
中文EN

QTEX QTREX Quantum Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1837493 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-19.6%
TTM EPS YoY25.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin0.7%
Operating margin-4,713.8%
Net margin-4,574.4%
FCF margin-3,447.8%
EBITDA margin-4,661.9%

Returns

ROE-397.9%
ROA-197.2%
ROIC (approx.)—
Asset turnover0.04x

Leverage & solvency

Liabilities / assets56.5%
Debt / equity0.00x
Current ratio1.56x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.75x
Accruals ratio-50.1%
Payout ratio—
Capex / revenue35.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$289,000$0$0——
Cost of revenue$287,000$0$0——
Gross profit$2,000$0$0——
R&D expense$7.50M$6.32M$7.32M$8.18M$4.07M
SG&A expense$5.53M$4.18M$4.06M$5.38M$6.94M
Operating income-$13.62M-$11.27M-$12.13M-$14.89M-$12.96M
Interest expense——$1.16M——
Pretax income-$13.22M-$11.05M-$11.29M-$14.98M-$17.19M
Income tax$0$0$0——
Net income-$13.22M-$11.05M-$11.29M-$14.98M-$17.19M
EBITDA-$13.47M-$11.10M-$12.02M-$14.84M-$12.94M
EPS (basic)-0.45-0.60-0.93-1.39-3.24
EPS (diluted)-0.45-0.60-0.93-1.39-3.24
Weighted avg. shares (diluted)29.62M18.52M12.10M10.79M5.31M
Banking
Noninterest expense——$722,000——
Deposits——$280,000$7.12M—
Balance sheet
Cash & equivalents$3.16M$5.11M$5.04M$6.84M$23.87M
Short-term investments—$700,000$2.30M$7.10M$120,000
Receivables————$639,000
Inventory$735,000$444,000———
Current assets$4.41M$6.81M$7.79M$14.49M$24.51M
PP&E, net$452,000$499,000$506,000$411,000$202,000
Total assets$5.34M$8.07M$9.31M$16.17M$25.87M
Current liabilities$2.82M$3.37M$2.98M$1.66M$4.31M
Total liabilities$3.02M$3.75M$3.57M$3.34M$5.52M
Shareholders' equity$2.32M$4.32M$5.74M$13.63M$23.73M
Shares outstanding35.95M24.25M15.65M11.34M10.09M
Cash flow statement
Operating cash flow-$9.86M-$9.37M-$9.69M-$9.21M-$6.68M
Capital expenditure$103,000$164,000$206,000$263,000$182,000
Free cash flow-$9.96M-$9.54M-$9.90M-$9.47M-$6.87M
Investing cash flow$565,000$1.49M$4.59M-$7.38M-$182,000
Financing cash flow$7.33M$7.90M$3.45M-$399,000$30.20M
Depreciation & amortization$150,000$171,000$111,000$54,000$25,000
Stock-based compensation$3.58M$1.89M$1.43M$4.88M$6.70M
Dividends paid———$399,000$199,000

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.